Build or buy? Key considerations for in-house manufacturing
For small and medium-sized biotech’s, for many years the common practice has been to outsource to both contract research organisations…
Interviews
Clinical trial diversity is a balancing act of time, quality, and money
How can (A)I help? AI chatbot to help understand the world of AI regulation
Sponsors must take on FDA’s diversity guidance to improve community trust
Advancing quality control measures vital for cell and gene therapy development
Mendel.ai software aims to save nurses time in pre-screening
NHS investment critical to drive cell and gene therapy research
How patient advocacy can lead to more successful and meaningful clinical trials
